Results 21 to 30 of about 42,260 (251)

The association between aspirin resistance and extent and severity of coronary atherosclerosis [PDF]

İstanbul Kuzey Klinikleri, 2018
INTRODUCTION[|]Uncontrolled inflammatory responses could contribute to the pathogenesis of many leading causes of human morbidity and mortality. Aspirin is an anti-inflammatory and antithrombotic drug that is used in the primary and secondary protection ...
Serkan Kahraman, Ali Dogan, Murat Ziyrek, Emrah Usta, Onder Demiroz, Cavlan Ciftci   +5 more
doaj   +2 more sources

Association between Multiplate-measured aspirin resistance and vitamin D deficiency in stable coronary artery disease. [PDF]

Arch Med Sci Atheroscler Dis, 2021
Surmen S, Ozer PK, Emet S, Govdeli EA, Elitok A.   +4 more
europepmc   +3 more sources

Aspirin resistance and blood biomarkers in predicting ischemic stroke recurrence: An exploratory study. [PDF]

Brain Circ, 2022
Dash P, Singh VK, Gautam D, Pathak A, Kumar A, Mishra SP, Dash D, Mishra VN, Joshi D, Chaurasia RN.   +9 more
europepmc   +2 more sources

Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy. [PDF]

Int J Mol Sci, 2022
Khan H, Kanny O, Syed MH, Qadura M.
europepmc   +3 more sources

To study the mechanism of panax notoginseng in the treatment of aspirin resistance in the secondary prevention of stroke based on TLR4/MyD88/NF-κB signaling pathway: A study protocol. [PDF]

Medicine (Baltimore), 2022
Wang H, Yuan J, Wang Y, Chen J.
europepmc   +2 more sources

Genetic factors related to aspirin resistance using the Multiplate® device in Hong Kong Chinese patients with stable coronary heart disease. [PDF]

Heliyon
Zeng W, Chu TT, Chow EY, Hu M, Fok BS, Chan JC, Yan BP, Tomlinson B.   +7 more
europepmc   +3 more sources

The prevalence and associated factors of aspirin resistance among prophylactic aspirin users [PDF]

Romanian Journal of Neurology, 2021
Background. Aspirin is an antiplatelet used for the secondary prevention after vascular events. It is also suggested for the primary prevention of vascular events in high risk people, however, despite using standard prophylactic doses, aspirin resistance
Samaneh Ghorbani-Shirkouhi, Fatemeh Ashouri, Saeideh Aghayari Sheikh Neshin, Alia Saberi, Bahador Hasanzadeh, Parisa Shahshahani   +5 more
doaj   +1 more source

Aspirin resistance in patients with acute coronary syndrome. Part 2

Кардиоваскулярная терапия и профилактика, 2011
Aim. In patients with acute coronary syndrome (ACS), to investigate the prevalence of aspirin resistance, its clinical features, prognostic effects, and potential correction. Material and methods.
N. S. Frolova, R. M. Shakhnovich, E. M. Kaznacheeva, O. V. Sirotkina, A. B. Dobrovolskyi   +4 more
doaj   +1 more source

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN

Рациональная фармакотерапия в кардиологии, 2015
Low dose aspirin reduces the secondary incidence of myocardial infarction and stroke. Drug resistance to aspirin might result in treatment failure.
A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin   +3 more
doaj   +3 more sources

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

Platelets, 2018
Essential thrombocythemia (ET) and polycythemia vera (PV) are myeloproliferative neoplasms (MPN) with an increased risk of arterial and venous thrombosis.
Andréas Perrier-Cornet, Jean-Christophe Ianotto, Fanny Mingant, Maëla Perrot, Eric Lippert, Hubert Galinat   +5 more
doaj   +1 more source